Internet/Social Media Platforms with Character Space Limitations— Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 18, 2014
April 24, 2020
b4147d06-9886-4255-90c9-3bc62c0c7374
Related Documents
Drug Interaction Information in Human Prescription Drug and Biological Product Labeling
Guidance DocumentOctober 21, 2024Center for Drug Evaluation and Research
Distributing Scientific and Medical Publications on Risk Information for Approved Prescription Drugs and Biological Products—Recommended Practices
Guidance DocumentJune 11, 2014Center for Drug Evaluation and Research
Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices
Guidance DocumentDecember 30, 2011Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.